LUNG CANCER (LOCALLY ADVANCED OR METASTATIC)
Clinical trials for LUNG CANCER (LOCALLY ADVANCED OR METASTATIC) explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER (LOCALLY ADVANCED OR METASTATIC) trials appear
Sign up with your email to follow new studies for LUNG CANCER (LOCALLY ADVANCED OR METASTATIC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo targets KRAS lung cancer in patients who Can't have surgery
Disease control OngoingThis trial is testing a combination of the immunotherapy drug tislelizumab plus two chemotherapy drugs (albumin-bound paclitaxel and a platinum agent) in 30 people with a specific type of lung cancer called KRAS-mutant non-small cell lung cancer. The participants have advanced or…
Matched conditions: LUNG CANCER (LOCALLY ADVANCED OR METASTATIC)
Sponsor: Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New scan could reveal hidden cancer spread
Diagnosis OngoingThis early-phase trial tests a radioactive imaging agent called Technetium-99m HYNIC-FAPI in 15 people with metastatic lung, pancreas, breast, or colorectal cancer. The goal is to see how well it highlights tumors on SPECT/CT scans. Researchers will measure where the agent goes i…
Matched conditions: LUNG CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: PHASE1 • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC